These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 808641)

  • 41. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On the mode of action of BCG.
    Mitchell MS; Kirkpatrick D; Mokyr MB; Gery I
    Nat New Biol; 1973 Jun; 243(128):216-8. PubMed ID: 4197570
    [No Abstract]   [Full Text] [Related]  

  • 43. Differences in sensitivity to a cytotoxic anti-thymus-derived lymphocyte serum of cells mediating delayed-onset reactions in guinea pigs to hapten-protein conjugates and contactants.
    Godfrey HP
    Cell Immunol; 1976 Mar; 22(1):28-42. PubMed ID: 819141
    [No Abstract]   [Full Text] [Related]  

  • 44. Transfer of adoptive immunity to tuberculosis in mice.
    Lefford MJ
    Infect Immun; 1975 Jun; 11(6):1174-81. PubMed ID: 806520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin.
    Strapagiel D; Kasztalska K; Druszczyńska M; Kowalewicz-Kulbat M; Vrba A; Matusiak A; Chmiela M; Rudnicka W
    Folia Histochem Cytobiol; 2008; 46(3):353-9. PubMed ID: 19056540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Delayed type hypersensitivity reactions to "Candida albicans" in mice (author's transl)].
    Hurtrel B; Lagrange PH
    Ann Immunol (Paris); 1978; 129 C(5):653-68. PubMed ID: 367260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice.
    Greenberg AH; Playfair JH
    Clin Exp Immunol; 1974 Jan; 16(1):99-109. PubMed ID: 4143189
    [No Abstract]   [Full Text] [Related]  

  • 49. The immune response to the cell wall of Mycobacterium bovis BCG.
    Orme IM
    Clin Exp Immunol; 1988 Mar; 71(3):388-93. PubMed ID: 3289800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody to the murine type 3 complement receptor inhibits T lymphocyte-dependent recruitment of myelomonocytic cells in vivo.
    Rosen H; Milon G; Gordon S
    J Exp Med; 1989 Feb; 169(2):535-48. PubMed ID: 2521356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of BCG vaccination on murine leprosy in C57BL/6 and C3H mice.
    Lagrange PH; Hurtrel B
    Ann Immunol (Paris); 1979; 130C(5):687-709. PubMed ID: 393159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Murine immune responses to oral BCG immunization in the presence or absence of prior BCG sensitization.
    Cross ML; Lambeth MR; Aldwell FE
    Immunol Cell Biol; 2010 Feb; 88(2):224-7. PubMed ID: 19918257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Active immunoprophylaxis and immunotherapy in two mouse lymphoma models.
    Ghose T; Guclu A; Tai J; Norvell ST; MacDonald AS
    J Natl Cancer Inst; 1976 Aug; 57(2):303-15. PubMed ID: 794497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of a single exposure to ultraviolet radiation on Mycobacterium bovis bacillus Calmette-Guerin infection in mice.
    Jeevan A; Kripke ML
    J Immunol; 1989 Nov; 143(9):2837-43. PubMed ID: 2681417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cellular immune response to Mycobacterium bovis (BCG) in genetically-susceptible and resistant congenic mouse strains.
    Bourassa D; Forget A; Pelletier M; Skamene E; Turcotte R
    Clin Exp Immunol; 1985 Oct; 62(1):31-8. PubMed ID: 3905097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo and in vitro antitumor activity expressed by cells of concomitantly immune mice.
    Tuttle RL; Knick VC; Stopford CR; Wolberg G
    Cancer Res; 1983 Jun; 43(6):2600-5. PubMed ID: 6133611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunopotentiation with BCG. IV. Factors affecting the magnitude of an antitumor response.
    Hawrylko E; Mackaness GB
    J Natl Cancer Inst; 1973 Nov; 51(5):1683-8. PubMed ID: 4587143
    [No Abstract]   [Full Text] [Related]  

  • 58. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide.
    Marusić M
    Exp Hematol; 1978 Oct; 6(9):725-37. PubMed ID: 361429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Properties of peritoneal exudate lymphocytes that mediate tuberculin delayed-type hypersensitivity and anti-tuberculosis immunity. I. The effect of cytotoxic agents.
    Lefford MJ
    Immunology; 1980 Nov; 41(3):635-42. PubMed ID: 7461705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW; Niederkorn JY
    J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.